TFOS DEWS II Definition and Classification Report

Ocular Surface

Volumn 15, Issue 3, 2017, Pages 276-283

  Craig, Jennifer P ^a   Nichols, Kelly K ^b   Akpek, Esen K ^c   Caffery, Barbara ^d   Dua, Harminder S ^e   Joo, Choun Ki ^f   Liu, Zuguo ^g   Nelson, J Daniel ^h,i   Nichols, Jason J ^b   Tsubota, Kazuo ^j   Stapleton, Fiona ^k  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Toronto Health Care System   (Canada)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f The Catholic University of Korea   (South Korea)

^g XIAMEN UNIVERSITY   (China)

^h HEALTHPARTNERS INSTITUTE   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k UNIVERSITY OF NEW SOUTH WALES   (Australia)

more..

Author keywords

Aqueous deficient; Classification; Definition; Dry eye disease; Evaporative; Mechanism

Indexed keywords

CLINICAL ASSESSMENT; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRY EYE; HOMEOSTASIS; HUMAN; MEDICAL TERMINOLOGY; NEUROPATHIC PAIN; NEUROTROPISM; OCULAR SURFACE DISEASE; PATHOPHYSIOLOGY; PHYSICAL DISEASE BY BODY FUNCTION; REVIEW; TFOS DEWS II DEFINITION AND CLASSIFICATION SUBCOMMITTEE; EYE; KERATOCONJUNCTIVITIS SICCA; LACRIMAL FLUID;

DRY EYE SYNDROMES; EYE; HUMANS; KERATOCONJUNCTIVITIS SICCA; TEARS;

EID: 85025470412     PISSN: 15420124     EISSN: 19375913     Source Type: Journal    
DOI: 10.1016/j.jtos.2017.05.008     Document Type: Review

References (23)

1. Bron, A.J., dePaiva, C.S., Chauhan, S.K., Bonini, S., Gabison, E.E., Jain, S., et al. TFOS DEWS II Pathophysiology report. Ocul Surf 15 (2017), 438–510.
2. Lemp, M.A., Report of the national eye institute/industry workshop on clinical trials in dry eyes. CLAO J 21:4 (1995), 221–232.
3. Behrens, A., Doyle, J.J., Stern, L., Chuck, R.S., McDonnell, P.J., Azar, D.T., et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 25:8 (2006), 900–907.
4. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop, Ocul Surf 2007:5 (2007), 75–92.
5. Willcox, M.D.P., Argüeso, P., Georgiev, G., Holopainen, J., Laurie, G., Millar, T., et al. TFOS DEWS II Tear Film report. Ocul Surf 15 (2017), 366–403.
6. Baudouin, C., A new approach for better comprehension of diseases of the ocular surface. J Fr Ophtalmol 30 (2007), 239–246.
7. Baudouin, C., Messmer, E.M., Aragona, P., Geerling, G., Akova, Y.A., Benítez-del-Castillo, J., et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol 100:3 (2016), 300–306.
8. Belmonte, C., Nichols, J.J., Cox, S.M., Brock, J.A., Begley, C.G., Bereiter, D.A., et al. TFOS DEWS II pain and sensation report. Ocul Surf 15 (2017), 404–437.
9. Stapleton, F., Alves, M., Bunya, V.Y., Jalbert, I., Lekhanont, K., Malet, F., et al. TFOS DEWS II Epidemiology report. Ocul Surf 15 (2017), 334–365.
10. Nichols, J.J., Willcox, M.D., Bron, A.J., Belmonte, C., Ciolino, J.B., Craig, J.P., et al. The TFOS international workshop on contact lens discomfort: executive summary. Invest Ophthalmol Vis Sci 54 (2013), TFOS7–TFOS13.
11. Nelson, J.D., Shimazaki, J., Benitez-del-Castillo, J.M., Craig, J.P., McCulley, J.P., Den, S., et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 52:4 (2011), 1930–1937.
12. Merriam-Webster Dictionary 2016. https://www.merriam-webster.com.
13. Chao, C., Golebiowski, B., Cui, Y., Stapleton, F., Development of a Chinese version of the ocular comfort index. Invest Ophthalmol Vis Sci 55:6 (2014), 3562–3571.
14. Shimazaki, J., Goto, E., Ono, M., Shimmura, S., Tsubota, K., Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology 105:8 (1998), 1485–1488.
15. Wolffsohn, J.S., Arita, R., Chalmers, R., Djalilian, A., Dogru, M., Dumbleton, K., et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf 15 (2017), 539–574.
16. Jones, L., Downie, L.E., Korb, D., Benitez-del-Castillo, J.M., Dana, R., Deng, S.X., et al. TFOS DEWS II Management and Therapy report. Ocul Surf 15 (2017), 575–628.
17. Gomes, J.A.P., Azar, D.T., Baudouin, C., Efron, N., Hirayama, M., Horwath-Winter, J., et al. TFOS DEWS II Iatrogenic report. Ocul Surf 15 (2017), 511–538.
18. Lemp, M.A., Crews, L.A., Bron, A.J., Foulks, G.N., Sullivan, B.D., Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea 31:5 (2012), 472–478.
19. Latkany, R.L., Lock, B., Speaker, M., Nocturnal lagophthalmos: an overview and classification. Ocul Surf 4:1 (2006), 44–53.
20. Viso, E., Rodríguez-Ares, M.T., Abelenda, D., Oubiña, B., Gude, F., Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci 53:6 (2012), 2601–2606.
21. Lienert, J.P., Tarko, L., Uchino, M., Christen, W.G., Schaumberg, D.A., Long-term natural history of dry eye disease from the Patient's perspective. Ophthalmology 123:2 (2016), 425–433.
22. Viso, E., Gude, F., Rodríguez-Ares, M.T., The association of meibomian gland dysfunction and other common ocular diseases with dry eye: a population-based study in Spain. Cornea 30:1 (2011), 1–6.
23. Tong, L., Chaurasia, S.S., Mehta, J.S., Beuerman, R.W., Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in Singapore. Invest Ophthalmol Vis Sci 51 (2010), 3449–3454.